OTCPK:DRWK.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Drägerwerk AG & Co. KGaA operates as medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. More Details


Snowflake Analysis

Flawless balance sheet and undervalued.


Similar Companies

Share Price & News

How has Drägerwerk KGaA's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: DRWK.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

DRWK.F

1.1%

US Medical Equipment

1.0%

US Market


1 Year Return

n/a

DRWK.F

15.4%

US Medical Equipment

13.6%

US Market

Return vs Industry: Insufficient data to determine how DRWK.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how DRWK.F performed against the US Market.


Shareholder returns

DRWK.FIndustryMarket
7 Day0%1.1%1.0%
30 Day-2.0%1.5%-0.4%
90 Dayn/a12.0%8.9%
1 Yearn/a16.4%15.4%16.2%13.6%
3 Year-17.6%-17.6%73.3%68.8%40.2%30.8%
5 Yearn/a149.6%130.6%89.6%68.2%

Price Volatility Vs. Market

How volatile is Drägerwerk KGaA's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Drägerwerk KGaA undervalued compared to its fair value and its price relative to the market?

34.4%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: DRWK.F ($90) is trading below our estimate of fair value ($137.12)

Significantly Below Fair Value: DRWK.F is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: DRWK.F is good value based on its PE Ratio (14.3x) compared to the US Medical Equipment industry average (49.4x).

PE vs Market: DRWK.F is good value based on its PE Ratio (14.3x) compared to the US market (18.4x).


Price to Earnings Growth Ratio

PEG Ratio: DRWK.F's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: DRWK.F is good value based on its PB Ratio (1.5x) compared to the US Medical Equipment industry average (3.9x).


Next Steps

Future Growth

How is Drägerwerk KGaA forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

-5.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: DRWK.F's earnings are forecast to decline over the next 3 years (-5.3% per year).

Earnings vs Market: DRWK.F's earnings are forecast to decline over the next 3 years (-5.3% per year).

High Growth Earnings: DRWK.F's earnings are forecast to decline over the next 3 years.

Revenue vs Market: DRWK.F's revenue (2.5% per year) is forecast to grow slower than the US market (9.7% per year).

High Growth Revenue: DRWK.F's revenue (2.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: DRWK.F's Return on Equity is forecast to be low in 3 years time (13.4%).


Next Steps

  • Explore growth companies in the Healthcare industry.

Past Performance

How has Drägerwerk KGaA performed over the past 5 years?

-2.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: DRWK.F has high quality earnings.

Growing Profit Margin: DRWK.F's current net profit margins (3.1%) are higher than last year (1.5%).


Past Earnings Growth Analysis

Earnings Trend: DRWK.F's earnings have declined by 2% per year over the past 5 years.

Accelerating Growth: DRWK.F's earnings growth over the past year (136.9%) exceeds its 5-year average (-2% per year).

Earnings vs Industry: DRWK.F earnings growth over the past year (136.9%) exceeded the Medical Equipment industry -0.2%.


Return on Equity

High ROE: DRWK.F's Return on Equity (11.7%) is considered low.


Next Steps

Financial Health

How is Drägerwerk KGaA's financial position?


Financial Position Analysis

Short Term Liabilities: DRWK.F's short term assets (€1.7B) exceed its short term liabilities (€1.1B).

Long Term Liabilities: DRWK.F's short term assets (€1.7B) exceed its long term liabilities (€967.9M).


Debt to Equity History and Analysis

Debt Level: DRWK.F's debt to equity ratio (16.6%) is considered satisfactory.

Reducing Debt: DRWK.F's debt to equity ratio has reduced from 34.5% to 16.6% over the past 5 years.

Debt Coverage: DRWK.F's debt is well covered by operating cash flow (115.4%).

Interest Coverage: DRWK.F's interest payments on its debt are well covered by EBIT (8.5x coverage).


Balance Sheet


Next Steps

Dividend

What is Drägerwerk KGaA current dividend yield, its reliability and sustainability?

0.27%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: DRWK.F's dividend (0.27%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.66%).

High Dividend: DRWK.F's dividend (0.27%) is low compared to the top 25% of dividend payers in the US market (4.68%).


Stability and Growth of Payments

Stable Dividend: DRWK.F is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: DRWK.F is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: DRWK.F is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of DRWK.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.3yrs

Average management tenure


CEO

Stefan Dräger (57 yo)

15.17yrs

Tenure

€2,315,126

Compensation

Mr. Stefan A. Dräger, Dipl.-Ing. (BA), has been the Chief Executive Officer and Chairman of the Executive Board at Drägerwerk Verwaltungs AG, a General Partner of Drägerwerk AG & Co. KGaA (formerly known a ...


CEO Compensation Analysis

Compensation vs Market: Stefan's total compensation ($USD2.75M) is below average for companies of similar size in the US market ($USD4.56M).

Compensation vs Earnings: Stefan's compensation has increased by more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Stefan Dräger
Chairman of the Executive Board - Drägerwerk Verwaltungs AG15.17yrs€2.32m0.61%
€ 9.1m
Gert-Hartwig Lescow
CFO, Executive Board Member for IT & Vice Chairman of Executive Board - Drägerwerk Verwaltungs AG5.42yrs€1.50mno data
Anton Schrofner
Chief Medical Officer & Member of Executive Board - Drägerwerk Verwaltungs AG5.42yrs€1.10mno data
Rainer Klug
Chief Security Officer & Member of Executive Board - Drägerwerk Verwaltungs AG5.08yrs€956.88kno data
Reiner Piske
Chief Sales and Human Resources Officer & Member of Executive Board - Drägerwerk Verwaltungs AG4.83yrs€1.09mno data
Stephan Kruse
Head of Global Operations & Member of Supervisory Board2.33yrs€20.00kno data
Welf Böttcher
Head of Corporate Communicationsno datano datano data

5.3yrs

Average Tenure

52.5yo

Average Age

Experienced Management: DRWK.F's management team is seasoned and experienced (5.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Stephan Kruse
Head of Global Operations & Member of Supervisory Board2.33yrs€20.00kno data
Thorsten Grenz
Independent Member of Supervisory Board12.33yrs€40.00kno data
Stefan Lauer
Independent Chairman of Supervisory Board2.33yrs€70.00kno data
Uwe Lüders
Independent Member of Supervisory Board12.33yrs€30.00kno data
Reinhard Zinkann
Independent Member of Supervisory Board12.33yrs€20.00kno data
Thomas Rickers
Member of Supervisory Board20.67yrs€20.00kno data
Siegfrid Kasang
Vice Chairman of Supervisory Board15.67yrs€40.00kno data
Daniel Friedrich
Member of Supervisory Board14yrs€30.00kno data
Maria Dietz
Member of Supervisory Board2.33yrs€20.00kno data
Nike Benten
Member of Supervisory Board4.58yrs€20.00kno data
Bettina van Almsick
Member of Supervisory Board4.25yrs€20.00kno data
Astrid Hamker
Member of Supervisory Board2.33yrs€20.00kno data

8.5yrs

Average Tenure

61yo

Average Age

Experienced Board: DRWK.F's board of directors are considered experienced (8.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.6%.


Top Shareholders

Company Information

Drägerwerk AG & Co. KGaA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Drägerwerk AG & Co. KGaA
  • Ticker: DRWK.F
  • Exchange: OTCPK
  • Founded: 1889
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €1.254b
  • Listing Market Cap: €1.488b
  • Shares outstanding: 18.76m
  • Website: https://www.draeger.com

Number of Employees


Location

  • Drägerwerk AG & Co. KGaA
  • Moislinger Allee 53-55
  • Lübeck
  • Schleswig-Holstein
  • 23558
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DRW3DB (Deutsche Boerse AG)YesPreferred SharesDEEURJan 1992
DRW5DB (Deutsche Boerse AG)GENUSSSCHEINE EUR25.56 (PERPETUAL) SER.ADEEURJan 1992
DRW3XTRA (XETRA Trading Platform)YesPreferred SharesDEEURJan 1992
0K5ELSE (London Stock Exchange)YesPreferred SharesGBEURJan 1992
DRWK.FOTCPK (Pink Sheets LLC)YesPreferred SharesUSUSDJan 1992
DRW3DBATS-CHIXE (BATS 'Chi-X Europe')YesPreferred SharesGBEURJan 1992
OXDRW3SWX (SIX Swiss Exchange)YesPreferred SharesCHCHFJan 1992
DRW3WBAG (Wiener Boerse AG)YesPreferred SharesATEURJan 1992
DRW7DB (Deutsche Boerse AG)GENUSSSCHEINE EUR25.56 (PERPETUAL) SER.KDEEURNov 1993
DRW1DB (Deutsche Boerse AG)GENUSSSCHEINE EUR25.56 (PERPETUAL) SER.DDEEURSep 1998
DWRK.FOTCPK (Pink Sheets LLC)GENUSSSCHEINE EUR25.56 (PERPETUAL) SER.DUSUSDSep 1998
DRW8DB (Deutsche Boerse AG)Common SharesDEEURJun 2010
0MT8LSE (London Stock Exchange)Common SharesGBEURJun 2010
DRW8XTRA (XETRA Trading Platform)Common SharesDEEURJun 2010
DGWP.FOTCPK (Pink Sheets LLC)Common SharesUSUSDJun 2010
DRW8DBATS-CHIXE (BATS 'Chi-X Europe')Common SharesGBEURJun 2010
DRW8ETLX (Eurotlx)Common SharesITEURJun 2010

Biography

Drägerwerk AG & Co. KGaA operates as medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/19 05:39
End of Day Share Price2020/08/26 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.